In the heated arena of the U.S. presidential race, Vice President Kamala Harris has been making waves with her pointed critiques of former President Donald Trump’s business history. During a rally in Charlotte, North Carolina, on September 12, Harris unveiled her proposal for a $50,000 tax deduction aimed at small business startups. She then took a direct jab at Trump, asserting, “You know, not everybody started out with $400m on a silver platter and then filed for bankruptcy six times.”

Harris’s remarks have sparked a flurry of fact-checking, with many turning to a recent article from Al Jazeera that delves into the veracity of these claims. The article references a comprehensive 2018 analysis by The New York Times, revealing that Trump did indeed receive approximately $413 million from his father, Fred Trump, over his lifetime. However, this sum was not a single lump sum at the start of his career but rather dispersed over many years.

Trump harris debate on screen

During a recent debate, Trump countered Harris’s claims, stating, “I wasn’t given $400m. I wish I was. My father was a Brooklyn builder. Brooklyn, Queens. And a great father, and I learned a lot from him. But I was given a fraction of that, a tiny fraction, and I built it into many, many billions of dollars.” The debate further intensified when Harris reiterated her points in a conversation hosted by Oprah Winfrey.

The Al Jazeera article also examines the claim of Trump’s six bankruptcies, confirming its accuracy. Trump’s financial struggles included high-profile bankruptcies such as the Trump Taj Mahal casino in 1991 and Trump Entertainment Resorts in 2009, among others. Experts have noted that while Trump did experience these financial setbacks, they are not uncommon in the business world.

Our Ruling

While Harris’s statement about Trump’s business beginnings contains elements of truth, it omits significant details. The New York Times investigation clarifies that Trump did not start his business career with $400 million readily available. Instead, he had the prospect of inheriting a portion of his father’s substantial real estate empire. This nuanced reality leads us to rate Harris’s statement as Half True.

Conclusion

As the presidential race progresses, the scrutiny of candidates’ claims remains crucial. Harris’s comments highlight the ongoing debate about wealth and privilege in America, while Trump’s rebuttal underscores the complexities of his business legacy. The full story, as always, is layered and multifaceted.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Gene Editing: A Promising Frontier in Biotechnology

Gene editing technology is swiftly emerging as a transformative force in both healthcare and agriculture, particularly through tools like CRISPR-Cas9, which offer precise methods to modify genes and promise to revolutionize treatment for genetic disorders, cancer, and infectious diseases.

Empowering the Gig Economy: AXA’s Tailored Protection

Angela Wong, Chief Marketing and Customer Officer at AXA Hong Kong & Macau, underscores the critical need for comprehensive insurance solutions for gig workers.

By |November 24, 2024|Categories: Article, Business, Insurance|Tags: , |0 Comments

Ethical Deployment of AI in Healthcare: AMA’s Guiding Strategies

The AMA highlights that AI's integration must be guided by the fundamental principles of medical ethics: patient autonomy, beneficence, nonmaleficence, and justice.

By |November 24, 2024|Categories: Article, Healthcare, Technology Ethics|Tags: , |0 Comments

AI’s Role in Revolutionizing Medical Education

AI, which simulates human intelligence, is reshaping various sectors, particularly healthcare. The ability to perform complex tasks, such as diagnostics and personalized healthcare, is no longer confined to human capabilities alone.

By |November 23, 2024|Categories: Article, Education, Technology|Tags: , |0 Comments

AI Chatbots in Chronic Disease Diagnosis

A recent study published in Nature on July 25, 2024, unveils a cutting-edge chatbot named Chat Ella, designed to assist in the diagnosis of chronic diseases.

Revolutionizing Genetic Research with CRISPR-Cas Technology

CRISPR-Cas technology is not just a tool but a gateway to understanding the genetic influences on diseases.